Outcome of ischemic mitral valve repair in patients with non-st elevation myocaridal infarction

Thai Minnh Nguyen1,2, Sinh Hien Nguyen1, Thanh Phi Long Nguyen1, Dinh Trung Ta1, Trong Tan Nguyen1, Quoc Hung Doan2,3,
1 Hanoi Heart Hospital
2 Hanoi Medical University
3 Vinmec Hospital

Main Article Content

Abstract

Objective: Our study aimed to describe patient’s characteristics, as well as to evaluate the short-term and 12-month outcomes of patients with non-ST-elevation myocardial infarction having severe ischemic mitral regurgitation, who underwent coronary artery bypass grafting with or without concomitant mitral valve repair. Methods: A retrospective study was conducted on 39 patients who underwent CABG at Hanoi Heart Hospital from January 2020 to December 2022. Preoperative, intraoperative, postoperative, and 12-month follow-up data were collected and compared between two groups: those who underwent mitral valve repair and those who did not. Results: Among the 39 patients (13 islolated CABG, 26 CABG with mitral valve repair), the repair group had a higher preoperative mitral regurgitation severity compared to the non-repair group (2.9 ± 0.2 vs. 2.6 ± 0.2, p=0.006). Mitral regurgitation improved in both groups postoperatively; however, at 12 months, the repair group showed significantly lower mitralregurgitation (p=0.041). There were no significant differences between the two groups in left ventricular function, postoperative and 12-month mortality, or postoperative complications. However, the repair group had longer aortic cross-clamp times (p=0.002) and a trend toward more early complications. Conclusion: Mitral valve repair combined with coronary artery bypass grafting in the group of severe ischemic mitral valve regurgitation reduced the degree of valve regurgitation after 12 months compared with isolated coronary artery bypass grafting.

Article Details

References

1. AATS Ischemic Mitral Regurgitation Consensus Guidelines Writing Committee, Kron IL, LaPar DJ, et al. 2016 update to The American Association for Thoracic Surgery (AATS) consensus guidelines: Ischemic mitral valve regurgitation. J Thorac Cardiovasc Surg. 2017;153(5):e97-e114. doi:10.1016/j.jtcvs.2017.01.031
2. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic Mitral Regurgitation. Circulation. 2001;103(13):1759-1764. doi:10.1161/01.CIR.103.13.1759
3. Schroder JN, Williams ML, Hata JA, et al. Impact of mitral valve regurgitation evaluated by intraoperative transesophageal echocardiography on long-term outcomes after coronary artery bypass grafting. Circulation. 2005;112(9 Suppl):I293-298. doi:10.1161/CIRCULATIONAHA.104.523472
4. Authors/Task Force members, Windecker S, Kolh P, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541-2619. doi:10.1093/eurheartj/ehu278
5. Gelsomino S, Lorusso R, De Cicco G, et al. Five-year echocardiographic results of combined undersized mitral ring annuloplasty and coronary artery bypass grafting for chronic ischaemic mitral regurgitation. Eur Heart J. 2008;29(2):231-240. doi:10.1093/eurheartj/ehm468
6. Benedetto U, Melina G, Roscitano A, et al. Does combined mitral valve surgery improve survival when compared to revascularization alone in patients with ischemic mitral regurgitation? A meta-analysis on 2479 patients. J Cardiovasc Med (Hagerstown). 2009;10(2):109-114. doi:10.2459/JCM.0b013e32831c84b0
7. Mihaljevic T, Lam BK, Rajeswaran J, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol. 2007;49(22):2191-2201. doi:10.1016/j.jacc.2007.02.043
8. Aklog L, Filsoufi F, Flores KQ, et al. Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation. 2001;104(12 Suppl 1):I68-75. doi:10.1161/hc37t1.094706
9. Kang DH, Kim MJ, Kang SJ, et al. Mitral valve repair versus revascularization alone in the treatment of ischemic mitral regurgitation. Circulation. 2006;114(1 Suppl):I499-503. doi:10.1161/CIRCULATIONAHA.105.000398
10. Fattouch K, Guccione F, Sampognaro R, et al. POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial. J Thorac Cardiovasc Surg. 2009;138(2):278-285. doi:10.1016/j.jtcvs.2008.11.010
11. Chan KMJ, Punjabi PP, Flather M, et al. Coronary Artery Bypass Surgery With or Without Mitral Valve Annuloplasty in Moderate Functional Ischemic Mitral Regurgitation. Circulation. 2012;126(21):2502-2510. doi:10.1161/CIRCULATIONAHA.112.143818
12. Hung J, Papakostas L, Tahta SA, et al. Mechanism of Recurrent Ischemic Mitral Regurgitation After Annuloplasty. Circulation. 2004;110(11_suppl_1):II-85. doi:10.1161/01.CIR.0000138192.65015.45
13. Michler RE, Smith PK, Parides MK, et al. Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation. N Engl J Med. 2016;374(20):1932-1941. doi:10.1056/NEJMoa1602003
14. Virk SA, Tian DH, Sriravindrarajah A, et al. Mitral valve surgery and coronary artery bypass grafting for moderate-to-severe ischemic mitral regurgitation: Meta-analysis of clinical and echocardiographic outcomes. J Thorac Cardiovasc Surg. 2017;154(1):127-136. doi:10.1016/j.jtcvs.2017.03.039
15. Kim BJ, Kim YS, Kim HJ, et al. Concomitant mitral valve surgery in patients with moderate ischemic mitral regurgitation undergoing coronary artery bypass grafting. Journal of Thoracic Disease. 2018;10(6). doi:10.21037/jtd.2018.05.148